Nanomedicine for T‐Cell Mediated Immunotherapy (Adv. Mater. 22/2024)

Nanomedicine Nanomedicines, with their diverse, flexible, and intelligent features, can enhance T cell-based therapy for various diseases. The article number 2301770 by Weisheng Guo, Xing-Jie Liang, and co-workers focuses on T-cell immunotherapy and how nanotechnology can improve its efficacy and safety, provides a deeper understanding of the mechanisms and challenges involved in using nanomedicines to augment T-cell mediated immunotherapy.